Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men

By W. Finkle, Sander Greenland, Gregory K. Ridgeway, J. Adams, M. A. Frasco, M. Cook, J. Fraumeni, R. Hoover. PLoS ONE, 2014

693 citations recorded by the source corpus.

Background An association between testosterone therapy (TT) and cardiovascular disease has been reported and TT use is increasing rapidly. Methods We conducted a cohort study of the risk of acute non-fatal myocardial infarction (MI) following an initial TT prescription (N = 55,593) in a large health-care database. We compared the incidence rate of MI in the 90 days following the initial prescription (post-prescription interval) with the rate in the one year prior to the initial prescription (pre-prescription interval) (post/pre). We also compared post/pre rates in a cohort of men prescribed phosphodiesterase type 5 inhibitors (PDE5I; sildenafil or tadalafil, N = 167,279), and compared TT prescription post/pre rates with the PDE5I post/pre rates, adjusting for potential confounders using doubly robust estimation. Results In all subjects, the post/pre-prescription rate ratio (RR) for TT prescription was 1.36 (1.03, 1.81). In men aged 65 years and older, the RR was 2.19 (1.27, 3.77) for TT prescription and 1.15 (0.83, 1.59) for PDE5I, and the ratio of the rate ratios (RRR) for TT prescription relative to PDE5I was 1.90 (1.04, 3.49). The RR for TT prescription increased with age from 0.95 (0.54, 1.67) for men under age 55 years to 3.43 (1.54, 7.56) for those aged ≥75 years (ptrend = 0.03), while no trend was seen for PDE5I (ptrend = 0.18). In men under age 65 years, excess risk was confined to those with a prior history of heart disease, with RRs of 2.90 (1.49, 5.62) for TT prescription and 1.40 (0.91, 2.14) for PDE5I, and a RRR of 2.07 (1.05, 4.11). Discussion In older men, and in younger men with pre-existing diagnosed heart disease, the risk of MI following initiation of TT prescription is substantially increased.

Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/d1b2769214aec795aa86092e8397b1f1b99ccd68

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. S. I. Bolleddu
  2. Kinjal Shah
  3. J. L. Rodgers
  4. S. Panguluri
  5. K. Karia
  6. Lydia E Rodgers
  7. Jarrod Jones
  8. Sahit Vanthenapalli

Citations in the corpus